Increased Hospital Stay and Allograft Disfunction in Renal Transplant Recipients with Cyp2c19 AA Variant in SNP rs4244285-Reference-Cited by-同舟云学术

Increased Hospital Stay and Allograft Disfunction in Renal Transplant Recipients with Cyp2c19 AA Variant in SNP rs4244285

Published:2012-11-21 Issue:2 Volume:41 Page:480-487
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Bosó Virginia,Herrero María José,Bea Sergio,Galiana María,Marrero Patricia,Marqués María Remedios,Hernández Julio,Sánchez-Plumed Jaime,Poveda José Luis,Aliño Salvador F.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference42 articles.

1. Practical recommendations for pharmacogenomics-based prescription: 2010 ESF–UB Conference on Pharmacogenetics and Pharmacogenomics

2. From Pharmacokinetics to Pharmacogenomics: A New Approach to Tailor Immunosuppressive Therapy

3. Impact of Cytochrome P450 3A and ATP-Binding Cassette Subfamily B Member 1 Polymorphisms on Tacrolimus Dose-Adjusted Trough Concentrations Among Korean Renal Transplant Recipients

4. Galiana M Herrero MJ Bosó V Bea S Ros E Sánchez-Plumed J Poveda JL Aliño SF (2012) Pharmacogenetics of immunosuppressive drugs in renal transplantation, in Renal Transplantation - Updates and Advances ( Long L , ed, ed) pp 143–162, InTech, Rijeka, Croatia.

5. CYP3A5 and ABCB1 polymorphisms in donor and recipient: impact on Tacrolimus dose requirements and clinical outcome after renal transplantation

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-drug interaction between diltiazem and tacrolimus in relation to CYP3A5 genotype status in Chinese pediatric patients with nephrotic range proteinuria: a retrospective study;Frontiers in Pharmacology;2024-09-03

2. Assessment of omeprazole and famotidine effects on the pharmacokinetics of tacrolimus in patients following kidney transplant–randomized controlled trial;Frontiers in Pharmacology;2024-04-04

3. Developments in pharmacogenetics, pharmacogenomics, and personalized medicine;Pharmacological Research;2024-02

4. Safety analysis of co-administering tacrolimus and omeprazole in renal transplant recipients – A review;Biomedicine & Pharmacotherapy;2023-10

5. The impact of cytochrome P450 3A5 genotype on early tacrolimus metabolism and clinical outcomes in lung transplant recipients;International Journal of Clinical Pharmacy;2021-12-03